109 related articles for article (PubMed ID: 21530305)
1. Baseline variation and associations between subject characteristics and five cytokine biomarkers of vaginal safety among healthy non-pregnant women in microbicide trials.
Fichorova RN; Lai JJ; Schwartz JL; Weiner DH; Mauck CK; Callahan MM
Cytokine; 2011 Jul; 55(1):134-40. PubMed ID: 21530305
[TBL] [Abstract][Full Text] [Related]
2. Assessment of cervicovaginal cytokine levels following exposure to microbicide Nisin gel in rabbits.
Aranha CC; Gupta SM; Reddy KV
Cytokine; 2008 Jul; 43(1):63-70. PubMed ID: 18513989
[TBL] [Abstract][Full Text] [Related]
3. Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission.
Yang J; Li L; Jin H; Tan S; Qiu J; Yang L; Ding Y; Jiang ZH; Jiang S; Liu S
AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1498-508. PubMed ID: 22867271
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo.
Trifonova RT; Pasicznyk JM; Fichorova RN
Antimicrob Agents Chemother; 2006 Dec; 50(12):4005-10. PubMed ID: 17030562
[TBL] [Abstract][Full Text] [Related]
5. Guiding the vaginal microbicide trials with biomarkers of inflammation.
Fichorova RN
J Acquir Immune Defic Syndr; 2004 Oct; 37 Suppl 3(Suppl 3):S184-93. PubMed ID: 16419271
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of cervicovaginal inflammation for the assessment of microbicide safety.
Cummins JE; Doncel GF
Sex Transm Dis; 2009 Mar; 36(3 Suppl):S84-91. PubMed ID: 19218890
[TBL] [Abstract][Full Text] [Related]
7. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
[TBL] [Abstract][Full Text] [Related]
8. Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection.
Chow SS; Craig ME; Jones CA; Hall B; Catteau J; Lloyd AR; Rawlinson WD
Cytokine; 2008 Oct; 44(1):78-84. PubMed ID: 18703348
[TBL] [Abstract][Full Text] [Related]
9. Toward early safety alert endpoints: exploring biomarkers suggestive of microbicide failure.
Mauck CK; Lai JJ; Weiner DH; Chandra N; Fichorova RN; Dezzutti CS; Hillier SL; Archer DF; Creinin MD; Schwartz JL; Callahan MM; Doncel GF
AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1475-86. PubMed ID: 23885658
[TBL] [Abstract][Full Text] [Related]
10. A study of the potential of the pig as a model for the vaginal irritancy of benzalkonium chloride in comparison to the nonirritant microbicide PHI-443 and the spermicide vanadocene dithiocarbamate.
D'Cruz OJ; Erbeck D; Uckun FM
Toxicol Pathol; 2005; 33(4):465-76. PubMed ID: 16036864
[TBL] [Abstract][Full Text] [Related]
11. The association between maternal cervicovaginal proinflammatory cytokines concentrations during pregnancy and subsequent early-onset neonatal infection.
Kalinka J; Krajewski P; Sobala W; Wasiela M; Brzezińska-Błaszczyk E
J Perinat Med; 2006; 34(5):371-7. PubMed ID: 16965223
[TBL] [Abstract][Full Text] [Related]
12. Role of the vaginal microbiological ecosystem and cytokine profile in the promotion of cervical dysplasia: a case-control study.
Behbakht K; Friedman J; Heimler I; Aroutcheva A; Simoes J; Faro S
Infect Dis Obstet Gynecol; 2002; 10(4):181-6. PubMed ID: 12648311
[TBL] [Abstract][Full Text] [Related]
13. Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product.
Amaral E; Perdigao A; Souza MH; Mauck C; Waller D; Zaneveld L; Faundes A
Contraception; 2006 May; 73(5):542-7. PubMed ID: 16627043
[TBL] [Abstract][Full Text] [Related]
14. Decreased proinflammatory cytokines in cervicovaginal fluid, as measured in midgestation, are associated with preterm delivery.
Kalinka J; Sobala W; Wasiela M; Brzezińska-Błaszczyk E
Am J Reprod Immunol; 2005 Aug; 54(2):70-6. PubMed ID: 16105098
[TBL] [Abstract][Full Text] [Related]
15. A disproportionate increase in IL-1beta over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth.
Genc MR; Witkin SS; Delaney ML; Paraskevas LR; Tuomala RE; Norwitz ER; Onderdonk AB
Am J Obstet Gynecol; 2004 May; 190(5):1191-7. PubMed ID: 15167817
[TBL] [Abstract][Full Text] [Related]
16. Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives.
Fichorova RN; Bajpai M; Chandra N; Hsiu JG; Spangler M; Ratnam V; Doncel GF
Biol Reprod; 2004 Sep; 71(3):761-9. PubMed ID: 15128598
[TBL] [Abstract][Full Text] [Related]
17. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH).
Nikolaitchouk N; Andersch B; Falsen E; Strömbeck L; Mattsby-Baltzer I
APMIS; 2008 Apr; 116(4):263-77. PubMed ID: 18397461
[TBL] [Abstract][Full Text] [Related]
18. Lymph draining from foot joints in rheumatoid arthritis provides insight into local cytokine and chemokine production and transport to lymph nodes.
Olszewski WL; Pazdur J; Kubasiewicz E; Zaleska M; Cooke CJ; Miller NE
Arthritis Rheum; 2001 Mar; 44(3):541-9. PubMed ID: 11263768
[TBL] [Abstract][Full Text] [Related]
19. Variation in vaginal immune parameters and microbial hydrolytic enzymes in bacterial vaginosis positive pregnant women with and without Mobiluncus species.
Culhane JF; Nyirjesy P; McCollum K; Goldenberg RL; Gelber SE; Cauci S
Am J Obstet Gynecol; 2006 Aug; 195(2):516-21. PubMed ID: 16643824
[TBL] [Abstract][Full Text] [Related]
20. Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women.
Genc MR; Vardhana S; Delaney ML; Onderdonk A; Tuomala R; Norwitz E; Witkin SS;
Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):152-6. PubMed ID: 15358455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
